Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reviva Pharmaceuticals Hldg Inc (NQ: RVPH ) 1.230 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Reviva Pharmaceuticals Hldg Inc < Previous 1 2 3 4 Next > Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst October 07, 2024 The FDA's approval of Bristol Myers Squibb's Cobenfy for schizophrenia opens doors for Reviva's brilaroxazine, a multi-receptor antipsychotic. Via Benzinga Exposures Product Safety RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024 August 14, 2024 RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH May 16, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH May 16, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Reviva... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH May 14, 2024 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH May 13, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - RVPH May 13, 2024 WHY: NEW YORK, NY - (NewMediaWire) - May 13, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Reviva... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga RVPH LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – RVPH April 25, 2024 From The Rosen Law Firm, P.A. Via Business Wire REVIVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reviva Pharmaceuticals Holdings, Inc. on Behalf of Reviva Stockholders and Encourages Investors to Contact the Firm April 25, 2024 From Bragar Eagel & Squire Via GlobeNewswire RVPH Stock Earnings: Reviva Pharmaceuticals Misses EPS for Q4 2023 April 15, 2024 RVPH stock results show that Reviva Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs January 23, 2024 These three companies are developing treatments for brain diseases that have a great deal of potential, making them top neuroscience stocks. Via InvestorPlace Reviva to Present at Webull LIVE! Healthcare Webinar on January 17 January 10, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Friday's Pre-Market Session December 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 18, 2023 Via Benzinga Life Science Investor Forum: Presentations Now Available for Online Viewing December 15, 2023 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire Life Science Investor Forum Agenda Announced for December 14th, 2023 December 12, 2023 From Virtual Investor Conferences Via GlobeNewswire Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum December 11, 2023 From Virtual Investor Conferences Via GlobeNewswire Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock October 30, 2023 Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 30, 2023 Via Benzinga Could This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trial October 30, 2023 Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) announced the topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine signaling modulator in Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session October 30, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session October 27, 2023 Via Benzinga Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV September 29, 2023 Via ACCESSWIRE Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV September 22, 2023 Via ACCESSWIRE Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023 September 20, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session August 17, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 17, 2023 It's time for another dive into the biggest pre-market stock movers this morning as we check out the latest news on Thursday! Via InvestorPlace RedChip Launches 'Small Stocks, Big Money' Podcast August 02, 2023 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.